2012
DOI: 10.1097/mjt.0b013e3181f0cbb4
|View full text |Cite
|
Sign up to set email alerts
|

Use of Physostigmine for Hallucinogenic Plant Poisoning in a Teenager

Abstract: The objective of this study was to utilize a case report to review the use of physostigmine for jimsonweed intoxication. A 15-year-old girl was found at school hallucinating and incoherent. Upon presentation to the emergency department, she was found to be tachycardic and confused with dilated pupils and dry, flushed, hot skin. She was admitted to our institution. Hallucinations and symptoms resolved after the use of physostigmine. She subsequently admitted to ingesting 'moonflower seeds,' which are derived fr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
15
0
1

Year Published

2014
2014
2021
2021

Publication Types

Select...
6
3
1

Relationship

1
9

Authors

Journals

citations
Cited by 26 publications
(16 citation statements)
references
References 10 publications
0
15
0
1
Order By: Relevance
“…Cerebral hypoxic-ischemic lesions could have occurred during asthmatic attacks, which were reported to be “so severe that Bacon would lie in bed for days, blue in the face, struggling for each breath” (Peppiatt, 2008, p. 11). In addition, since Bacon has been prescribed morphine and stramonium to ease his bronchial spasms (Peppiatt, 2008), toxic factors (Vella-Brincat and Macleod, 2007; Glatstein et al, 2012) might be considered, although unlikely as not associated with pronounced systemic manifestations; in addition, distorted percepts upon sustained fixation consistently occurred over decades (Sylvester, 1980). …”
mentioning
confidence: 99%
“…Cerebral hypoxic-ischemic lesions could have occurred during asthmatic attacks, which were reported to be “so severe that Bacon would lie in bed for days, blue in the face, struggling for each breath” (Peppiatt, 2008, p. 11). In addition, since Bacon has been prescribed morphine and stramonium to ease his bronchial spasms (Peppiatt, 2008), toxic factors (Vella-Brincat and Macleod, 2007; Glatstein et al, 2012) might be considered, although unlikely as not associated with pronounced systemic manifestations; in addition, distorted percepts upon sustained fixation consistently occurred over decades (Sylvester, 1980). …”
mentioning
confidence: 99%
“…14 Diagnosis can be difficult because of the wide range of signs and symptoms associated with anticholinergic toxicity and the difficulties associated with obtaining an accurate history in recreational drug ingestions. The estimated lethal dose of atropine in humans is .10 mg and that of scopolamine is .2-4 mg. 17 Toxicity usually occurs within 60 minutes of ingestion, and clinical symptoms may persist for 24-48 hours. 2 Clinical manifestations are caused by central or peripheral nervous system effects or both.…”
Section: Discussionmentioning
confidence: 99%
“…Se recomienda una dosis de 0,02 mg / kg de fisostigmina (rango 0,5-2 mg) pasarlos en 2 minutos usando un acceso venoso periférico, reevaluando periódicamente el estado neurológico. Esto se puede repetir cada 10 minutos si es necesario, hasta un máximo de 4 mg. Los efectos adversos de la fisostigmina son de naturaleza colinérgica (diaforesis, emesis, diarrea, incontinencia urinaria, broncorrea, bradicardia) y aparecen 10-20 minutos después de la administración, o cuando se produce efecto pico en sistema nervioso central (14,15).…”
Section: Las Plantasunclassified